Page last updated: 2024-09-04

tariquidar and quinoline-3-carboxamide

tariquidar has been researched along with quinoline-3-carboxamide in 1 studies

Compound Research Comparison

Studies (tariquidar)	Trials (tariquidar)	Recent Studies (post-2010) (tariquidar)	Studies (quinoline-3-carboxamide)	Trials (quinoline-3-carboxamide)	Recent Studies (post-2010) (quinoline-3-carboxamide)
210	16	138	22	1	17

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fung, KL; Gottesman, MM; Hall, MD; Innis, RB; Kannan, P; Kumar, JS; Moen, JK; Mulder, J; Weidner, LD	1

Other Studies

1 other study(ies) available for tariquidar and quinoline-3-carboxamide

Article	Year
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein. Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:2 Topics: 3T3 Cells; Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Brain; Cell Line; Cell Line, Transformed; Humans; KB Cells; MCF-7 Cells; Mice; Quinolines	2016

Article

Year

Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein.

Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:2

Topics: 3T3 Cells; Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Brain; Cell Line; Cell Line, Transformed; Humans; KB Cells; MCF-7 Cells; Mice; Quinolines

2016